A single-center, randomized, double-blind, placebo-controlled multiple-ascending dose study of QX002N injection in subjects with ankylosing spondylitis

Status: Not yet recruiting

Phase of Trial: Phase I

Latest Information Update: 04 Aug 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

03 Aug 2020 As per Clinical trial registry front page of this trial, date of first enrolment is given as 1 Aug 2020 (no clear info if this is the date when actual enrolment has begin), while as per inside view of trial record, Overall status is not yet recruiting (last updated on June 2020).Retaining status as not yet recruiting based on this for now.Pls update further.
03 Aug 2020 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com